Improvement in the health of HIV-infected persons in care: reducing disparities. - Wikidata - wikimedia - TriplyDB

Improvement in the health of HIV-infected persons in care: reducing disparities.

Improvement in the health of HIV-infected persons in care: reducing disparities.

http://www.wikidata.org/entity/Q36303074

about

Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009 Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients HIV-1 Genetic Variability and Clinical Implications Barriers to Hepatitis C Virus (HCV) Treatment Initiation in Patients With Human Immunodeficiency Virus/HCV Coinfection: Lessons From the Interferon Era.The complexity of HIV persistence and pathogenesis in the lung under antiretroviral therapy: challenges beyond AIDS.Immune activation in HIV-infected aging women on antiretrovirals--implications for age-associated comorbidities: a cross-sectional pilot study.California's "Bridge to Reform": identifying challenges and defining strategies for providers and policymakers implementing the Affordable Care Act in low-income HIV/AIDS care and treatment settings.Ten-year Survival by Race/Ethnicity and Sex Among Treated, HIV-infected Adults in the United States.Primer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding Domain Addressing the challenges of the HIV continuum of care in high-prevalence cities in the United States.A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse.Trends in hospital deaths among human immunodeficiency virus-infected patients during the antiretroviral therapy era, 1995 to 2011 Comparing longitudinal CD4 responses to cART among non-perinatally HIV-infected youth versus adults: Results from the HIVRN Cohort.Gender-Related Risk Factors Improve Mortality Predictive Ability of VACS Index Among HIV-Infected Women Patterns of HIV service use and HIV viral suppression among patients treated in an academic infectious diseases clinic in North Carolina.Substance Abuse Treatment, HIV/AIDS, and the Continuum of Response for People Who Inject Drugs.Increased Prevalence of Controlled Viremia and Decreased Rates of HIV Drug Resistance Among HIV-Positive People Who Use Illicit Drugs During a Community-wide Treatment-as-Prevention Initiative Sex differences in soluble markers vary before and after the initiation of antiretroviral therapy in chronically HIV-infected individuals.Higher quality communication and relationships are associated with improved patient engagement in HIV care Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States Immune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques.The Rationale, Design, and Initial Efficacy of SystemCHANGE(™) -HIV: A Systems-Based Intervention to Improve Physical Activity in People Living with HIV.High Hepatitis C cure rates among black and non-black HIV-infected adults in an urban center.Sex, Race, and HIV Risk Disparities in Discontinuity of HIV Care After Antiretroviral Therapy Initiation in the United States and Canada.Trends in Racial and Ethnic Disparities in Antiretroviral Therapy Prescription and Viral Suppression in the United States, 2009-2013.Black:White Disparities in HIV Mortality in the United States: 1990-2009.Incidence, Long-Term Outcomes, and Healthcare Utilization of Patients With Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Disseminated Mycobacterium avium Complex From 1992-2015.Comprehensive Ryan White Assistance and HIV Clinical Outcomes: Retention in Care and Viral Suppression in a Medicaid Non-Expansion State.Increased Antiretroviral Therapy Use and Virologic Suppression in the Bronx in the Context of Multiple HIV Prevention Strategies.Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels.Racial/ethnic disparities in engagement in care and viral suppression in a large urban HIV clinic.Financial Barriers and Lapses in Treatment and Care of HIV-Infected Adults in a Southern State in the United States.Influence of model assumptions about HIV disease progression after initiating or stopping treatment on estimates of infections and deaths averted by scaling up antiretroviral therapy.The Contribution of Missed Clinic Visits to Disparities in HIV Viral Load Outcomes.The influence of race and comorbidity on the timely initiation of antiretroviral therapy among older persons living with HIV/AIDS.

P2860

Q28535233-0772EBE4-CAB8-4993-B252-FF7E1898D5F9 Q28548003-FBCEEA70-EB52-48F9-B0EB-425FABF8DBAE Q30352010-AB09C3A3-2D0A-42EB-9B1D-CC59CAE3A49F Q33629538-007F8440-D199-40C9-AAFA-2436838EB24F Q33705883-48EAD391-3575-48E9-8036-0EA5CD8CFE3A Q34749335-91E4C0CB-D588-498B-8267-5475FA79D3F1 Q35112164-FBF04CAF-BFC5-4B55-BF1D-18E122E23C8E Q35661732-A2F062DF-03F0-4955-BE12-F8D27C052609 Q35692184-0B0933B3-A396-4926-8817-78B7DAC4B4A7 Q35781306-6D20527D-39D7-48D2-B684-CE88ABE5DA98 Q35996628-7D5B07CF-EA5D-4E4F-B261-326580421DDB Q36030846-C932EF1F-48A4-4F62-BC12-FE09568ACF53 Q36275359-9BEFD5A8-B9B2-4BEB-B713-EE875E1CE931 Q36278787-3734D74A-A65F-4F54-8A77-99B12E8D5F1B Q36395144-BE96C891-F40D-44D1-A180-8A6862248B2A Q36454818-A4674BE2-4CB9-460F-BD6B-D885A13E03EE Q36543830-77975795-7255-4C76-8D00-B6704EEE4163 Q36957941-229E890E-5983-4EEA-AF84-8CBC6A51AFAC Q37119226-D10549DF-5C53-42A3-8BA2-B71F2933599F Q37272859-D8A9CE93-C756-4208-ABAA-2531E6F90FAD Q37406571-8D84AC08-0BB9-4C27-BC4D-B7B2C65EF717 Q37419317-BB7C756A-8EBE-4934-8964-104B8ABB0FA5 Q38401928-0B28AE6C-EFC7-43D0-874E-8BA224ED7EA5 Q38402291-FC8F3CAC-30C4-4BA4-A317-9974D88625DD Q39621488-81D5912D-6AFA-4222-984E-426EE95472D3 Q39983127-41D753BE-09B6-4590-AB8D-888C4EE9CDDA Q40106698-F26E9F1E-AD6B-484F-BE79-287007254E52 Q40225076-945E3D69-3A1C-4496-8B11-F7F461898E01 Q40785784-5C3A0FF8-A7F6-412B-B1B4-16626CCE102F Q42243024-EDB39132-D2DC-4FE3-BB84-7D46D7E997F0 Q43056078-82CB7AFC-780D-48A1-98AD-4C202EB568E0 Q50079426-376825EA-83F8-4E5A-9782-0761A4B974EE Q52648768-FE079B0C-C133-430A-AE80-B0A1EA675389 Q53791871-8BFC1C5C-BBEF-4957-A224-C04C757CB5AA Q53829397-9EA3E48C-2402-4822-8526-FB5F77CADE4B

P2860

Improvement in the health of HIV-infected persons in care: reducing disparities.

http://www.wikidata.org/entity/Q36303074

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Improvement in the health of HIV-infected persons in care: reducing disparities.

@ast

Improvement in the health of HIV-infected persons in care: reducing disparities.

@en

type

label

Improvement in the health of HIV-infected persons in care: reducing disparities.

@ast

Improvement in the health of HIV-infected persons in care: reducing disparities.

@en

prefLabel

Improvement in the health of HIV-infected persons in care: reducing disparities.

@ast

Improvement in the health of HIV-infected persons in care: reducing disparities.

@en

P1433

Q36303074-F8DF200D-8629-4706-8994-865EAB1E2513

P1476

Q36303074-73DE73CC-8369-44AF-B679-9FE6DBE2B60E

P2093

Q36303074-6CFDAAC2-6A2C-4C18-BD76-C7900BF5AF43

Q36303074-BBB31F2C-9732-4C39-AE08-F5C122917218

Q36303074-F9824CE7-C8D9-47A9-AA34-BAF759AB7B26

P2860

Q36303074-0AEA5769-5C5B-400B-AEF2-2D0F5519134F

Q36303074-0D45254E-73F8-45C4-86F0-09FE438E0CEE

Q36303074-0D842267-AF89-4349-911F-AECF9D67C348

Q36303074-0F70620B-ABC7-4492-A90C-EAA8D97E24EE

Q36303074-269FDEC3-394F-4D5C-A92C-39A0D026D931

Q36303074-30DE2DF9-802F-437C-8C3C-1CD56F136D63

Q36303074-31823EE5-CF35-4D2D-9E29-79404355C118

Q36303074-32CD5C5D-7193-4495-B2C9-12DAD817F997

Q36303074-343B4E75-AD1A-44BA-8841-B635340BE330

Q36303074-37E41350-5F76-4147-8F8A-F0616FF38404

P304

Q36303074-6A5563EE-5816-447C-98D6-67D5268521F0

P31

Q36303074-7F7D1F7D-9D21-4C83-AC53-C55B6530440F

P356

Q36303074-22B878D2-72D3-48BB-9BB4-87076A10A0F9

P407

Q36303074-2D35008B-8CD5-4073-BF8D-C0DD50BE1A5F

P433

Q36303074-FC0F4E62-20C5-4B6A-BB2A-B3D5837BDA04

P478

Q36303074-6721704F-B246-4F2E-A671-2FEA2C805C5F

P577

Q36303074-401EFCBB-3826-42BB-8E61-67D0B6EF9D1D

P5875

Q36303074-F28A7611-921F-4F8E-ABF6-56BE4B240FAB

P698

Q36303074-1AC1BF82-8CB5-4E2A-9B96-20B20A51D37C

P921

Q36303074-0772B160-FC5B-49C9-8EE0-DFDFF4CC574D

Q36303074-3A32771E-73F1-4B13-9F28-47702E5F4464

Q36303074-7205D122-373F-4EDC-ACF6-9D6AF123FF3A

P932

Q36303074-3241D552-23D9-4284-87E4-645B8991D028

P356

P1433

Clinical Infectious Diseases

P1476

Improvement in the health of HIV-infected persons in care: reducing disparities.

@en

P2093

Jeanne C Keruly

http://www.w3.org/2001/XMLSchema#string

John G Bartlett

http://www.w3.org/2001/XMLSchema#string

Richard D Moore

http://www.w3.org/2001/XMLSchema#string

P2860

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Assessing the relationship between seasonal and H1N1 influenza vaccination status in Michigan children, 2009-2010

Natural history of HIV infection in the era of combination antiretroviral therapy.

Health disparities and health equity: concepts and measurement.

Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature.

Identifying the impact of social determinants of health on disease rates using correlation analysis of area-based summary information.

Dramatic decline in the HIV-1 RNA level over calendar time in a large urban HIV practice.

Essential components of effective HIV care: a policy paper of the HIV Medicine Association of the Infectious Diseases Society of America and the Ryan White Medical Providers Coalition.

HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.

P304

1242-1251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIS654

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231225404

http://www.w3.org/2001/XMLSchema#string

P698

23019271

http://www.w3.org/2001/XMLSchema#string

P921

health disparity

P932

3466093

http://www.w3.org/2001/XMLSchema#string